Get access to our best features
Get access to our best features
Published 15 days ago

‘Transformative’ sickle cell treatment approved for NHS use

  • Around 4,000 people with sickle cell disease in England could benefit from a “life-changing” new treatment after it was given the green light for use in the NHS.
  • Health leaders said that voxelotor, also known as oxbryta and made by Pfizer, will significantly improve quality of life for patients with the condition.
  • The drug works by helping haemoglobin hold on to more oxygen, preventing red blood cells from becoming misshapen, and has been approved for NHS use after a price reduction.
Insights by Ground AI
Does this summary seem wrong?

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)